Tag: Anjeso

pharmaceutical manufacturing

Malvern-Based Pharmaceutical Company Expects to Raise $6.2 Million from Public Stock Offering 

Malvern-based Baudax Bio is selling a little over 11.8 million shares of its common stock in a public stock offering that is expected…

Malvern’s Baudax Bio Closes $50 Million Loan Deal to Officially Launch Its Non-Opioid Pain Med

Malvern-based Baudax Bio has signed a loan deal with Marathon Asset Management worth $50 million to support the launch of its intravenous and non…

Malvern’s Baudax Bio Turns to Nontraditional Methods to Promote New, Non-Opioid Pain Med

Baudax Bio launched its new, non-opioid pain medication earlier this week, but due to the ongoing coronavirus crisis, the Malvern-based company is relying…